These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 11455209
1. Inhibition by eicosapentaenoic acid of oxidized-LDL- and lysophosphatidylcholine-induced human coronary artery smooth muscle cell production of endothelin. Kohno M, Ohmori K, Wada Y, Kondo I, Noma T, Fujita N, Mizushige K, Mandal AK. J Vasc Res; 2001; 38(4):379-88. PubMed ID: 11455209 [Abstract] [Full Text] [Related]
2. Suppression by eicosapentaenoic acid of oxidized low-density lipoprotein and lysophosphatidylcholine-induced migration in cultured rat vascular smooth muscle cells. Kohno M, Yasunari K, Minami M, Kano H, Maeda K, Yoshikawa J. Metabolism; 2000 May; 49(5):560-2. PubMed ID: 10831162 [Abstract] [Full Text] [Related]
3. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Hanehira T, Yoshikawa J. Circulation; 1998 Jul 28; 98(4):353-9. PubMed ID: 9711941 [Abstract] [Full Text] [Related]
4. Effects of cardiac natriuretic peptides on oxidized low-density lipoprotein- and lysophosphatidylcholine-induced human mesangial cell migration. Kohno M, Yasunari K, Maeda K, Kano H, Minami M, Hanehira T, Yoshikawa J. Hypertension; 2000 Apr 28; 35(4):971-7. PubMed ID: 10775571 [Abstract] [Full Text] [Related]
5. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Giardina JB, Tanner DJ, Khalil RA. Hypertension; 2001 Feb 28; 37(2 Pt 2):561-8. PubMed ID: 11230335 [Abstract] [Full Text] [Related]
6. The various effects of fractionated oxidized low density lipoproteins on the growth of smooth muscle cells in culture. Lin MT, Su WC, Cheng ML, Cheng KS, Chang WC, Wing LH, Jen CJ, Wu HL. J Biomed Sci; 1999 Feb 28; 6(4):260-8. PubMed ID: 10420083 [Abstract] [Full Text] [Related]
7. Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: role of PKC. Cox DA, Cohen ML. Am J Physiol; 1996 Oct 28; 271(4 Pt 2):H1706-10. PubMed ID: 8897967 [Abstract] [Full Text] [Related]
8. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C. McNair LL, Salamanca DA, Khalil RA. Hypertension; 2004 Apr 28; 43(4):897-904. PubMed ID: 14981072 [Abstract] [Full Text] [Related]
9. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, Yoshikawa J. Circ Res; 1997 Oct 28; 81(4):585-90. PubMed ID: 9314840 [Abstract] [Full Text] [Related]
10. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells. Yamakawa T, Eguchi S, Yamakawa Y, Motley ED, Numaguchi K, Utsunomiya H, Inagami T. Hypertension; 1998 Jan 28; 31(1 Pt 2):248-53. PubMed ID: 9453311 [Abstract] [Full Text] [Related]
11. Oxidized low-density lipoprotein enhances myogenic tone in the rabbit posterior cerebral artery through the release of endothelin-1. Xie H, Bevan JA. Stroke; 1999 Nov 28; 30(11):2423-29; discussion 2429-30. PubMed ID: 10548680 [Abstract] [Full Text] [Related]
12. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Watanabe T, Pakala R, Katagiri T, Benedict CR. Circulation; 2001 Jul 03; 104(1):16-8. PubMed ID: 11435331 [Abstract] [Full Text] [Related]
13. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol. Nishio E, Arimura S, Watanabe Y. Biochem Biophys Res Commun; 1996 Jun 14; 223(2):413-8. PubMed ID: 8670295 [Abstract] [Full Text] [Related]
14. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins. Haug C, Schmid-Kotsas A, Zorn U, Schuett S, Gross HJ, Gruenert A, Bachem MG. J Mol Cell Cardiol; 2001 Sep 14; 33(9):1701-12. PubMed ID: 11549348 [Abstract] [Full Text] [Related]
15. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide. Watanabe T, Takahashi K, Kanome T, Hongo S, Miyazaki A, Koba S, Katagiri T, Pakara R, Benedict CR. Hypertens Res; 2006 Oct 14; 29(10):821-31. PubMed ID: 17283870 [Abstract] [Full Text] [Related]
16. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation. Watanabe T, Pakala R, Katagiri T, Benedict CR. J Cardiovasc Pharmacol; 2002 Mar 14; 39(3):449-59. PubMed ID: 11862125 [Abstract] [Full Text] [Related]
17. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Yasunari K, Maeda K, Minami M, Yoshikawa J. Arterioscler Thromb Vasc Biol; 2001 Jun 14; 21(6):937-42. PubMed ID: 11397700 [Abstract] [Full Text] [Related]
18. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. J Biol Chem; 1996 Jul 26; 271(30):17791-7. PubMed ID: 8663300 [Abstract] [Full Text] [Related]
19. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. Wong JT, Tran K, Pierce GN, Chan AC, O K, Choy PC. J Biol Chem; 1998 Mar 20; 273(12):6830-6. PubMed ID: 9506985 [Abstract] [Full Text] [Related]
20. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Murohara T, Scalia R, Lefer AM. Circ Res; 1996 May 20; 78(5):780-9. PubMed ID: 8620597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]